THE INFLUENCE OF METABOLIC SYNDROME COMPONENTS ON THE DEVELOPMENT OF FETAL MACROSOMIA
Authors/Creators
Description
Fetal macrosomia, commonly defined as a birth weight of ≥4000 g or above the 90th percentile for gestational age, remains a frequent and clinically significant complication of pregnancy worldwide. Maternal metabolic syndrome (MetS), characterized by central obesity, insulin resistance or hyperglycemia, dyslipidemia, and arterial hypertension, is increasingly recognized as an important risk factor for excessive fetal growth. This review synthesizes current evidence on the pathophysiological mechanisms and clinical associations linking individual components of maternal MetS with fetal macrosomia and examines their combined predictive value. A narrative review of PubMed/MEDLINE and Scopus-indexed literature was conducted, focusing on cohort and case-control studies, systematic reviews, and meta-analyses published over the past two decades. The evidence indicates that maternal hyperglycemia and compensatory fetal hyperinsulinemia constitute the central pathogenic pathway of macrosomia, consistent with the Pedersen hypothesis. Maternal obesity independently and synergistically increases this risk through chronic low-grade inflammation, dysregulation of leptin and adiponectin, and enhanced placental nutrient transport. Elevated maternal triglycerides and altered lipid indices may further contribute to fetal overgrowth through glucose-independent mechanisms. In contrast, the relationship between hypertensive disorders and macrosomia is more heterogeneous and may be influenced by placental insufficiency, which can attenuate fetal growth. The coexistence of multiple metabolic syndrome components is associated with a substantially greater risk of macrosomia than the presence of individual risk factors alone. Overall, maternal metabolic syndrome components contribute to fetal overgrowth through overlapping but distinct mechanisms, with hyperglycemia, insulin resistance, and dyslipidemia demonstrating the most consistent associations. Early identification and integrated metabolic risk stratification during the first and second trimesters may improve the prediction and prevention of macrosomia-related perinatal complications.